214 related articles for article (PubMed ID: 34927495)
1. Evaluation of early de-escalation of empiric antimicrobial therapy in acute leukemia patients with febrile neutropenia at a large academic medical center.
Ly WJ; Brown EE; Pedretti Z; Auten J; Wilson WS
J Oncol Pharm Pract; 2023 Mar; 29(2):305-310. PubMed ID: 34927495
[TBL] [Abstract][Full Text] [Related]
2. Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged Neutropenia.
Alegria W; Marini BL; Gregg KS; Bixby DL; Perissinotti A; Nagel J
J Natl Compr Canc Netw; 2022 Feb; 20(3):245-252. PubMed ID: 35120305
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin.
Petteys MM; Kachur E; Pillinger KE; He J; Copelan EA; Shahid Z
J Oncol Pharm Pract; 2020 Apr; 26(3):632-640. PubMed ID: 31423947
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of empiric antibiotic de-escalation in febrile neutropenia.
Kroll AL; Corrigan PA; Patel S; Hawks KG
J Oncol Pharm Pract; 2016 Oct; 22(5):696-701. PubMed ID: 26227319
[TBL] [Abstract][Full Text] [Related]
5. Effect of Linezolid on Hematologic Recovery in Newly Diagnosed Acute Myeloid Leukemia Patients Following Induction Chemotherapy.
Nedved AN; DeFrates SR; Hladnik LM; Stockerl-Goldstein KE
Pharmacotherapy; 2016 Oct; 36(10):1087-1094. PubMed ID: 27521990
[TBL] [Abstract][Full Text] [Related]
6. Outcomes Associated with De-escalation of Antibiotics to Target Positive Cultures when Treating Febrile Neutropenia.
Rainess R; Campbell P; Santamala J; Kubin CJ; Mehta M
J Pharm Pract; 2024 Apr; 37(2):301-306. PubMed ID: 36201023
[No Abstract] [Full Text] [Related]
7. Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome.
Niessen FA; van Mourik MSM; Bruns AHW; Raijmakers RAP; de Groot MCH; van der Bruggen T
Antimicrob Resist Infect Control; 2020 May; 9(1):74. PubMed ID: 32460887
[TBL] [Abstract][Full Text] [Related]
8. Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial.
Aguilar-Guisado M; Espigado I; Martín-Peña A; Gudiol C; Royo-Cebrecos C; Falantes J; Vázquez-López L; Montero MI; Rosso-Fernández C; de la Luz Martino M; Parody R; González-Campos J; Garzón-López S; Calderón-Cabrera C; Barba P; Rodríguez N; Rovira M; Montero-Mateos E; Carratalá J; Pérez-Simón JA; Cisneros JM
Lancet Haematol; 2017 Dec; 4(12):e573-e583. PubMed ID: 29153975
[TBL] [Abstract][Full Text] [Related]
9. Infections in acute myeloid leukemia: an analysis of 382 febrile episodes.
Gupta A; Singh M; Singh H; Kumar L; Sharma A; Bakhshi S; Raina V; Thulkar S
Med Oncol; 2010 Dec; 27(4):1037-45. PubMed ID: 19830601
[TBL] [Abstract][Full Text] [Related]
10. Moxifloxacin versus levofloxacin for antibacterial prophylaxis in acute leukemia patients.
Lee P; Knoebel RW; Pisano J; Pettit NN
J Oncol Pharm Pract; 2019 Apr; 25(3):758-761. PubMed ID: 29310512
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of antibiotic short course for bloodstream infections in acute myeloid leukemia patients with febrile neutropenia: A retrospective comparative study.
Metais A; Torregrosa Diaz JM; Gallego Hernanz MP; Pichon M; Desmier D; Roblot F; Rammaert B
J Infect; 2022 Jan; 84(1):1-7. PubMed ID: 34715238
[TBL] [Abstract][Full Text] [Related]
12. Evaluating Initial Empiric Therapy for Neutropenic Fever in Vancomycin-Resistant Enterococcus-Colonized Patients.
Snyder M; Pasikhova Y; Baluch A
Cancer Control; 2021; 28():10732748211045593. PubMed ID: 34558349
[TBL] [Abstract][Full Text] [Related]
13. Impact of Fluoroquinolone Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML Patients.
Caro J; Madero-Marroquin R; Zubizarreta N; Moshier E; Tremblay D; Coltoff A; Lancman G; Fuller R; Rana M; Mascarenhas J; Jacobs SE
Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):903-911. PubMed ID: 36109322
[TBL] [Abstract][Full Text] [Related]
14. De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia.
Rearigh L; Stohs E; Freifeld A; Zimmer A
Ann Hematol; 2020 Aug; 99(8):1917-1924. PubMed ID: 32556455
[TBL] [Abstract][Full Text] [Related]
15. Management of febrile neutropenia in the perspective of antimicrobial de-escalation and discontinuation.
Schmidt-Hieber M; Teschner D; Maschmeyer G; Schalk E
Expert Rev Anti Infect Ther; 2019 Dec; 17(12):983-995. PubMed ID: 30686067
[No Abstract] [Full Text] [Related]
16. Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country.
Joudeh N; Sawafta E; Abu Taha A; Hamed Allah M; Amer R; Odeh RY; Salameh H; Sabateen A; Aiesh BM; Zyoud SH
BMC Infect Dis; 2023 Feb; 23(1):106. PubMed ID: 36814229
[TBL] [Abstract][Full Text] [Related]
17. [An unusual cause of febrile neutropenia: brucellosis].
Solmaz S; Asma S; Ozdoğu H; Yeral M; Turunç T
Mikrobiyol Bul; 2014 Oct; 48(4):669-73. PubMed ID: 25492662
[TBL] [Abstract][Full Text] [Related]
18. Discontinuation of antimicrobial therapy in adult neutropenic haematology patients: A prospective cohort.
Van de Wyngaert Z; Berthon C; Debarri H; Bories C; Bonnet S; Nudel M; Carpentier B; Legrand C; Barbieux S; Chauvet P; Simonnet A; Willaume A; Bossard JB; Renaud L; Wattebled KJ; Escure G; Branche N; Arib I; Titecat M; Quesnel B; Alfandari S
Int J Antimicrob Agents; 2019 Jun; 53(6):781-788. PubMed ID: 30831232
[TBL] [Abstract][Full Text] [Related]
19. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.
Stern A; Carrara E; Bitterman R; Yahav D; Leibovici L; Paul M
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012184. PubMed ID: 30605229
[TBL] [Abstract][Full Text] [Related]
20. Time to defervescence evaluation for extended- vs. standard-infusion cefepime in patients with acute leukemia and febrile neutropenia.
Crawford R; Perkins NB; Hobbs DA; Hobbs ALV
Pharmacotherapy; 2022 Oct; 42(10):798-805. PubMed ID: 36106434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
